beta
AVRO
AvroBio Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.
Market Cap: 59.7 Million
Primary Exchange: NASDAQ
Website: avrobio.com
Shares Outstanding: 44.6 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.3631406408121816
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Ethical Flags
Longest drawdown: 1662 trading days
From: 2018-09-26 To: 2024-03-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|